Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Germing

Showing results (91-100 of 339) with videos related to

Pageof 34
Sort By:
British Journal of Haematology|January 10, 2006
Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposalsUlrich Germing, Corinna Strupp, Andrea Kuendgen, et al.
Experimental Hematology|April 29, 2008
Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromesMichael Wulfert, Anna C Küpper, Christoph Tapprich, et al.
Annals of Hematology|April 28, 2006
Rituximab long-term maintenance therapy after autologous stem cell transplantation in patients with B-cell non-Hodgkin's lymphomaFrank Neumann, Stefani Harmsen, Simona Martin, et al.
Expert Review of Anticancer Therapy|July 24, 2020
Improving the accuracy of prognostication in chronic myelomonocytic leukemiaJennifer Kaivers, Esther Schuler, Barbara Hildebrandt, et al.
Annals of Hematology|November 5, 2005
Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemiaAndrea Kuendgen, Sabine Knipp, Frank Fox, et al.
Annals of Hematology|June 10, 2026
Prognostic impact of bone marrow iron and serum ferritin in patients with myelodysplastic syndromesAnnika Kasprzak, Felicitas Schulz, Kathrin Nachtkamp, et al.
Annals of Hematology|June 23, 2010
Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study GroupKatharina Götze, Uwe Platzbecker, Aristoteles Giagounidis, et al.
Annals of Hematology|May 6, 2017
A retrospective study evaluating the impact of infectious complications during azacitidine treatmentAnna Schuck, Marie-Christine Goette, Judith Neukirchen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 11, 2020
Falciparum malaria-induced secondary hemophagocytic lymphohistiocytosis successfully treated with ruxolitinibAndré Fuchs, Hans-Martin Orth, Ulrich Germing, et al.
Cancer|July 27, 2017
Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosisJudith Neukirchen, Michael Lauseker, Barbara Hildebrandt, et al.
Pageof 34

Showing results (91-100 of 339) with videos related to

Sort By:
Pageof 34
British Journal of Haematology|January 10, 2006
Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposalsUlrich Germing, Corinna Strupp, Andrea Kuendgen, et al.
Experimental Hematology|April 29, 2008
Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromesMichael Wulfert, Anna C Küpper, Christoph Tapprich, et al.
Annals of Hematology|April 28, 2006
Rituximab long-term maintenance therapy after autologous stem cell transplantation in patients with B-cell non-Hodgkin's lymphomaFrank Neumann, Stefani Harmsen, Simona Martin, et al.
Expert Review of Anticancer Therapy|July 24, 2020
Improving the accuracy of prognostication in chronic myelomonocytic leukemiaJennifer Kaivers, Esther Schuler, Barbara Hildebrandt, et al.
Annals of Hematology|November 5, 2005
Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemiaAndrea Kuendgen, Sabine Knipp, Frank Fox, et al.
Annals of Hematology|June 10, 2026
Prognostic impact of bone marrow iron and serum ferritin in patients with myelodysplastic syndromesAnnika Kasprzak, Felicitas Schulz, Kathrin Nachtkamp, et al.
Annals of Hematology|June 23, 2010
Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study GroupKatharina Götze, Uwe Platzbecker, Aristoteles Giagounidis, et al.
Annals of Hematology|May 6, 2017
A retrospective study evaluating the impact of infectious complications during azacitidine treatmentAnna Schuck, Marie-Christine Goette, Judith Neukirchen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 11, 2020
Falciparum malaria-induced secondary hemophagocytic lymphohistiocytosis successfully treated with ruxolitinibAndré Fuchs, Hans-Martin Orth, Ulrich Germing, et al.
Cancer|July 27, 2017
Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosisJudith Neukirchen, Michael Lauseker, Barbara Hildebrandt, et al.
Pageof 34